United Health Products, Inc.
UEEC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.25 | -0.40 | 0.41 | -0.07 |
| FCF Yield | -9.05% | -4.18% | -1.01% | -0.62% |
| EV / EBITDA | -7.49 | -21.30 | -41.22 | -4.46 |
| Quality | ||||
| ROIC | 153.89% | 261.09% | 203.45% | 3,229.04% |
| Gross Margin | 0.00% | 0.00% | 50.28% | 57.63% |
| Cash Conversion Ratio | 0.60 | 0.84 | 0.37 | 0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | 287.80% | -77.12% |
| Free Cash Flow Growth | 45.71% | -233.32% | 20.27% | 41.98% |
| Safety | ||||
| Net Debt / EBITDA | -0.50 | -0.28 | -0.42 | -0.01 |
| Interest Coverage | -18.38 | -20.88 | -35.54 | -48.20 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.14 | 0.54 | 0.00 |
| Cash Conversion Cycle | -65,400.19 | -71,690.07 | -23,894.19 | -12,066,695.60 |